The strong demand for MUSE further supports the belief that erectile dysfunction is a significant health issue and that MUSE offers a safe and effective treatment. This new building is located within the same business park as our current manufacturing facility in Lakewood, New Jersey. The Swedish filing consists of the FDA submission plus the results of a five-country European study that confirmed the results seen in the U.S. pivotal phase III study. The Swedish application follows the United Kingdom application which was filed in September 1996. The company has pioneered a unique therapy for erectile dysfunction, known as the transurethral system for erection.
Financial tables follow.
Inc. All rights reserved.